Why It Matters
Medicaid fraud costs federal and state governments billions of dollars annually, diverting funds from eligible recipients and straining public health budgets. Florida Senator Ashley Moody’s new legislation targets a specific gap in existing law — one that currently limits investigators’ ability to pursue individuals who fraudulently obtain Medicaid benefits, as opposed to providers who submit false billing claims.
If passed, the bill would give state Medicaid Fraud Control Units broader jurisdiction, potentially accelerating prosecutions and recovering taxpayer dollars at a time when federal deficit reduction is a central legislative priority.
What Happened
U.S. Senator Ashley Moody introduced the STOP FRAUD in Medicaid Act in the Senate on or around March 30, 2026. The bill is designed to close a legal gap that currently restricts state Medicaid Fraud Control Units to investigating fraudulent claims submitted by healthcare providers, leaving them with limited authority to pursue individual beneficiaries who deceive providers to obtain benefits they are not entitled to receive.
Moody, who previously served as Florida’s Attorney General, cited ongoing fraud investigations in multiple states as the driving force behind the legislation. A companion bill in the U.S. House of Representatives, sponsored by Republican Rep. Gabe Evans of Colorado, has already entered the committee review process ahead of a potential floor vote.
“I fought fraud as Florida’s Attorney General, recovering millions of dollars for taxpayers, and I am fighting it now as U.S. Senator, finding and closing gaps that exist in our laws,” Moody said in a statement. “The STOP FRAUD in Medicaid Act gives states the authority to catch and punish fraud fast.”
By the Numbers
- $9 billion — Estimated amount of suspected Medicaid fraud billed across 14 services in Minnesota, cited by Moody as a key motivation for the legislation.
- $180 million — Approximate total in settlements Moody secured related to fraudulent Medicaid claims during her tenure as Florida’s Attorney General.
- 14 — Number of Medicaid service categories in Minnesota flagged in fraud reports referenced by the Trump administration.
- February 2026 — When the Trump administration declared what it characterized as a “new war on fraud,” prompted in part by the Minnesota Medicaid fraud reports.
- March 2026 — Month in which federal officials opened a separate investigation in Florida regarding suspected fraudulent Medicaid claims.
Zoom Out
Medicaid fraud enforcement has become an increasingly prominent issue at both the state and federal levels. The Trump administration’s February announcement of intensified fraud oversight signaled a broader push to audit Medicaid rolls and tighten eligibility verification across multiple states, not only in Minnesota.
State Medicaid Fraud Control Units currently operate in all 50 states and receive federal matching funds, but their statutory authority has historically been narrower in scope when it comes to beneficiary-side fraud. Moody’s legislation reflects a growing legislative effort to give those units more prosecutorial tools as Medicaid enrollment and spending have expanded significantly following pandemic-era policy changes.
Rep. Gabe Evans of Colorado, the House bill’s sponsor, framed the issue in terms of program sustainability. “We must eliminate and be proactive against fraud within Medicaid and Medicare to protect the programs for those who truly need it,” Evans said. His support signals at least some bipartisan geographic reach for the proposal, with Republican co-sponsorship spanning states with varying Medicaid structures.
The broader federal fiscal environment — including ongoing debates over discretionary spending, deficit reduction, and potential Medicaid funding adjustments — adds political urgency to fraud-related legislation heading into the 2026 election cycle.
What’s Next
The House version of the STOP FRAUD in Medicaid Act is currently moving through committee review, which is a standard procedural step before a bill can advance to a full chamber vote. The Senate bill’s timeline will depend on committee scheduling and broader legislative priorities in the coming weeks.
The ongoing federal investigation into suspected Medicaid fraud in Florida may add additional momentum to the legislation at both the state and national level. No vote date has been publicly announced for either chamber as of publication.